hipec - YouTube
PDF) Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion: The University of Arizona early experience
OncoSurgery - Σπηλιώτης Ιωάννης - ΚΟΣΤΟΣ ΩΦΕΛΕΙΑ ΑΠΟ ΤΗΝ ΕΦΑΡΜΟΓΗ ΤΗΣ HIPEC ΣΤΗΝ ΠΕΡΙΤΟΝΑΪΚΗ ΚΑΚΟΗΘΕΙΑ Ολοκληρώθηκε πριν 1 μήνα η αναλυτική καταγραφή των δεδομένων μιας 15ετίας και 658 περιστατικών με περιτοναϊκή κακοήθεια,
Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbidity and Mortality | Semantic Scholar
John Spiliotis MD, PhD - Surgeon Oncologist, Director and Chairman Peritoneal Surface Oncology - Athens Medical Group & European Interbalkan Medical Center | LinkedIn
hipec - YouTube
Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbidity and Mortality | Semantic Scholar
John Spiliotis MD, PhD - Surgeon Oncologist, Director and Chairman Peritoneal Surface Oncology - Athens Medical Group & European Interbalkan Medical Center | LinkedIn
Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbidity and Mortality | Semantic Scholar
Complications after CRS and HIPEC | Download Table
Survival results in 49 patients after HIPEC (hyperthermic... | Download Scientific Diagram
Surgical Oncology | Rutgers Cancer Institute of New Jersey
Current Issue Table of Contents: European Journal of Surgical Oncology
Onco Surgery - Σπηλιώτης Ιωάννης - Χειρουργός Ογκολόγος
Onco Surgery - Σπηλιώτης Ιωάννης - Χειρουργός Ογκολόγος
Σπηλιώτης Ιωάννης - Oncosurgery Spiliotis - YouTube
Konstantinos Votanopoulos, MD, PhD, FACS | Atrium Health Wake Forest Baptist
Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbidity and Mortality | Semantic Scholar
Operating personnel safety during the administration of Hyperthermic Intraperitoneal Chemotherapy (HIPEC). | Semantic Scholar
Onco Surgery - Σπηλιώτης Ιωάννης - Χειρουργός Ογκολόγος
Significance of Urinary Tract Involvement in Patients Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy ( HIPEC) | Semantic Scholar
John Spiliotis MD, PhD - Surgeon Oncologist, Director and Chairman Peritoneal Surface Oncology - Athens Medical Group & European Interbalkan Medical Center | LinkedIn
